Allison L. Naleway, PhD

Senior Investigator
Kaiser Permanente Center for Health Research

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-41) Effectiveness of recombinant zoster vaccine against postherpetic neuralgia in a real-world setting
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-51) Influenza Vaccine Effectiveness in Ambulatory Care Settings among Pregnant Persons in the 2023-2024 Influenza Season
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-59) Tdap Vaccination Coverage During Pregnancy, 2016 Through 2023
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-731) Viruses Associated with Acute Respiratory Illness in a Community Cohort of Children and Adults, Oregon and Washington, United States, 2022 - 2023
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1951) Incidence of SARS-CoV-2 Infection among those 6 Months to 49 Years of Age in the Cascadia Prospective Cohort Study, Oregon and Washington, United States, July 1, 2022 – March 31, 2024
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT